Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease

BACKGROUND: The relationship between vedolizumab trough levels and combined endoscopic and clinical remission is unknown. OBJECTIVE: To compare vedolizumab trough levels in patients with and without combined remission within the first year of treatment. METHODS: We prospectively collected vedolizuma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:United European Gastroenterol J
Main Authors: Hanžel, Jurij, Sever, Nejc, Ferkolj, Ivan, Štabuc, Borut, Smrekar, Nataša, Kurent, Tina, Koželj, Matic, Novak, Gregor, Compernolle, Griet, Tops, Sophie, Gils, Ann, Drobne, David
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620872/
https://ncbi.nlm.nih.gov/pubmed/31316778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619840211
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados